Figure 5.
Appearance of human (top) and equine (bottom) BMDMSCs in monolayer for each of the 5 different treatment groups stained for alkaline phosphatase on day 14. Human BMDMSCs treated with AdBMP-2 and AdBMP-2/7 demonstrated osteogenic cell morphology compared to other treatment groups. Original magnification, 200x.